Zeynep T. Yuce

Eskisehir, 26000, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Self-Reported History of Herpes Zoster and Awareness of Zoster Vaccination Among Healthcare Workers: A Multicenter Cross-Sectional Study.

Self-Reported History of Herpes Zoster and Awareness of Zoster Vaccination Among Healthcare Workers: A Multicenter Cross-Sectional Study.

Journal: Vaccines

Published: June 18, 2026

Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye.

Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye.

Journal: EClinicalMedicine

Published: March 06, 2026

Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study.

Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: June 26, 2025

Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study.

Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study.

Journal: International journal of antimicrobial agents

Published: June 10, 2025

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.

Journal: Vaccines

Published: January 14, 2024

COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.

COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.

Journal: Vaccines

Published: November 16, 2023

Incidence and Features of Acute Ischemic Stroke in Patients Hospitalized with COVID-19: A Multi-center Study in Turkey.

Incidence and Features of Acute Ischemic Stroke in Patients Hospitalized with COVID-19: A Multi-center Study in Turkey.

Journal: Noro psikiyatri arsivi

Published: May 09, 2023

Surgeon-Specific Infection Rates and Risk Factors for Prosthetic Joint Infections.

Surgeon-Specific Infection Rates and Risk Factors for Prosthetic Joint Infections.

Journal: Journal of clinical practice and research

Published: January 20, 2023

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.

Journal: Vaccine

Published: April 13, 2022

The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors.

The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors.

Journal: Endocrine

Published: October 14, 2021

COVID-19: vaccination vs. hospitalization.

COVID-19: vaccination vs. hospitalization.

Journal: Infection

Published: September 18, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026